Biflavonoids Are Superior to Monoflavonoids in Inhibiting Amyloid-β Toxicity and Fibrillogenesis via Accumulation of Nontoxic Oligomer-like Structures
Authors:
- Eun-Rhan WooEWEun-Rhan Woo
- Golam SharoarGSGolam Sharoar
- Hong-Guang JinHJHong-Guang Jin
- Song Yub ShinSSSong Yub Shin
- Il-Seon ParkIPIl-Seon Park
- 15 March 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 50 (13) , 2445-2455
Abstract
Polymerization of monomeric amyloid-β peptides (Aβ) into soluble oligomers and insoluble fibrils is one of the major pathways triggering the pathogenesis of Alzheimer’s disease (AD). Using small molecules to prevent the polymerization of Aβ peptides can, therefore, be an effective therapeutic strategy for AD. In this study, we investigate the effects of mono- and biflavonoids in Aβ42-induced toxicity and fibrillogenesis and find that the biflavonoid taiwaniaflavone (TF) effectively and specifically inhibits Aβ toxicity and fibrillogenesis. Compared to TF, the monoflavonoid apigenin (AP) is less effective and less specific. Our data show that differential effects of the mono- and biflavonoids in Aβ fibrillogenesis correlate with their varying cytoprotective efficacies. We also find that other biflavonoids, namely, 2′,8′′-biapigenin, amentoflavone, and sumaflavone, can also effectively inhibit Aβ toxicity and fibrillogenesis, implying that the participation of two monoflavonoids in a single biflavonoid molecule enhances their activity. Biflavonoids, while strongly inhibiting Aβ fibrillogenesis, accumulate nontoxic Aβ oligomeric structures, suggesting that these are off-pathway oligomers. Moreover, TF abrogates the toxicity of preformed Aβ oligomers and fibrils, indicating that TF and other biflavonoids may also reduce the toxicity of toxic Aβ species. Altogether, our data clearly show that biflavonoids, possibly because of the possession of two Aβ binders separated by an appropriate size linker, are likely to be promising therapeutics for suppressing Aβ toxicity.Keywords
This publication has 41 references indexed in Scilit:
- Aβ Oligomers – a decade of discoveryJournal of Neurochemistry, 2007
- Conformation‐Dependent Anti‐Amyloid Oligomer Antibodies2006
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- Alzheimer's disease: the cholesterol connectionNature Neuroscience, 2003
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- New protease inhibitors prevent γ-secretase-mediated production of Aβ40/42 without affecting Notch cleavageNature Cell Biology, 2001
- Alzheimer's Disease: Genes, Proteins, and TherapyPhysiological Reviews, 2001
- Intake of flavonoids and risk of dementiaEuropean Journal of Epidemiology, 2000
- Normal Cellular Processing of the β‐Amyloid Precursor Protein Results in the Secretion of the Amyloid β Peptide and Related MoleculesaAnnals of the New York Academy of Sciences, 1993
- Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril proteinBiochemical and Biophysical Research Communications, 1984